Stockscreener 앱 받기
0.605
58.28%
-0.845
시간 외 거래:
.62
0.015
+2.48%
전일 마감가:
$1.45
열려 있는:
$1.46
하루 거래량:
5.50M
Relative Volume:
19.58
시가총액:
$13.47M
수익:
$74,000
순이익/손실:
$-13.43M
주가수익비율:
-0.0644
EPS:
-9.4
순현금흐름:
$-10.54M
1주 성능:
-62.19%
1개월 성능:
-87.35%
6개월 성능:
-90.71%
1년 성능:
-98.22%
1일 변동 폭
$0.5803
$1.5481
1주일 범위
$0.5803
$1.8184
52주 변동 폭
$0.5803
$39.84
Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile
명칭
Cyclacel Pharmaceuticals Inc
전화
908-517-7330
주소
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
CYCC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYCC
Cyclacel Pharmaceuticals Inc
|
0.605 | 38.02M | 74,000 | -13.43M | -10.54M | -9.40 |
|
ONC
Beone Medicines Ltd Adr
|
257.00 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
443.82 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.282 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
85.54 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
483.07 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2020-04-27 | 재개 | ROTH Capital | Buy |
| 2018-09-07 | 개시 | Ladenburg Thalmann | Buy |
| 2015-10-16 | 개시 | H.C. Wainwright | Buy |
| 2010-02-04 | 개시 | Roth Capital | Buy |
| 2009-10-28 | 개시 | Merriman | Buy |
| 2008-08-12 | 개시 | Piper Jaffray | Buy |
| 2008-03-12 | 재확인 | Cantor Fitzgerald | Buy |
| 2008-03-12 | 재확인 | Collins Stewart | Buy |
| 2008-03-12 | 재확인 | Needham & Co | Buy |
| 2007-11-27 | 재확인 | Cantor Fitzgerald | Buy |
| 2007-08-10 | 재확인 | Cantor Fitzgerald | Buy |
| 2007-06-04 | 재확인 | Needham & Co | Buy |
| 2007-04-23 | 개시 | Lazard Capital | Buy |
| 2007-04-10 | 개시 | Cantor Fitzgerald | Buy |
모두보기
Cyclacel Pharmaceuticals Inc 주식(CYCC)의 최신 뉴스
Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Listing Rule - marketscreener.com
Cyclacel Pharmaceuticals Declares Quarterly Cash Dividend - TipRanks
Cyclacel Pharmaceuticals (CYCC) Regains Nasdaq Compliance | CYCC Stock News - GuruFocus
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM - GuruFocus
Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement - marketscreener.com
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT | CYCC Stock News - GuruFocus
Cyclacel Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - Nasdaq
Cyclacel Dodges Delisting Risk: Stock Stabilizes Above $1, Secures Crucial Nasdaq Compliance - Stock Titan
Comparing Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Biodexa Pharmaceuticals (NASDAQ:BDRX) - Defense World
Cyclacel stock plunges to 52-week low of $1.95 amid market challenges - Investing.com Australia
(CYCCP) Proactive Strategies - news.stocktradersdaily.com
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.com - Defense World
CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE - The Manila Times
Cyclacel Pharmaceuticals Reports Q1 2025 Financial Results and Strategic Focus Shifts to Plogosertib Development - Nasdaq
Upcoming Stock Splits This Week (May 12 to May 16) – Stay Invested - The Globe and Mail
Fitters Clarifies Details Of Business Unit Disposal To Cyclacel - BusinessToday Malaysia
Cyclacel Pharmaceuticals (CYCC) to Release Earnings on Monday - Defense World
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by StockNews.com - Defense World
Trend Tracker for (CYCCP) - news.stocktradersdaily.com
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Shares Scheduled to Reverse Split on Monday, May 12th - Defense World
Cyclacel Pharmaceuticals Announces Reverse Stock Split - TipRanks
Cyclacel Pharmaceuticals (CYCC) Plans 1-for-16 Reverse Stock Split | CYCC Stock News - GuruFocus
Cyclacel Pharmaceuticals Announces Stock Split - marketscreener.com
Cyclacel Pharmaceuticals Announces 1-for-16 Reverse Stock Split Effective May 12, 2025 - Nasdaq
CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT - The Manila Times
Cyclacel Pharmaceuticals enters exchange agreement with Fitters - TipRanks
Cyclacel Pharmaceuticals (CYCC) Plans Strategic Acquisition and Rebranding | CYCC Stock News - GuruFocus
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCH - GuruFocus
Fitters swaps fire safety arm for 19.99% stake in Nasdaq biotech firm - The Malaysian Reserve
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN. BHD. ITS WHOLLY-OWNED SUBSIDIARY TO ACCELERATE GROWTH AND STOCKHOLDER VALUE - The Manila Times
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE - GlobeNewswire
Cyclacel's Major Transformation: 80% Stake in Malaysian Fire Safety Leader Signals Strategic Pivot - Stock Titan
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated by Analysts at StockNews.com - Defense World
Biotech Alert: Searches spiking for these stocks today - TipRanks
Stocks of Cyclacel Pharmaceuticals Inc (CYCC) are poised to climb above their peers - Sete News
Press Release Distribution & PR Platform - ACCESS Newswire
Examining Cyclacel Pharmaceuticals Inc (CYCC) more closely is necessary - uspostnews.com
The Psychology of Cyclacel Pharmaceuticals Inc Inc. (CYCC) Price Performance: Understanding Market Sentiment - investchronicle.com
Cyclacel Pharmaceuticals (CYCC) Announces Quarterly Dividend - GuruFocus
Cyclacel Pharmaceuticals expands share authorization By Investing.com - Investing.com India
Cyclacel Pharmaceuticals expands share authorization - Investing.com
Major Shareholders Set to Sell Stocks; Company (TICKER) to Reap No Proceeds | CYCC Stock News - GuruFocus
Cyclacel Pharmaceuticals Inc Inc. (CYCC) Price Performance: A Technical Analysis Perspective - investchronicle.com
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Could Actually Go To 1 In 12 Months - Marketing Sentinel
Was Cyclacel Pharmaceuticals Inc (CYCC)’s session last reading good? - uspostnews.com
StockNews.com Initiates Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World
Trading (CYCCP) With Integrated Risk Controls - news.stocktradersdaily.com
Cyclacel Pharmaceuticals announces preferred stock dividend By Investing.com - Investing.com Canada
Cyclacel Pharmaceuticals announces preferred stock dividend - Investing.com
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated at StockNews.com - Defense World
Cyclacel Pharmaceuticals Inc (CYCC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
1.24%
자본화:
|
볼륨(24시간):